Limula
PrivateLast Round
Debt
Dec 11, 2024
Total Funding Raised
$15.43M
Company Overview
Limula is a biotechnology company that develops an automated, closed-system platform for the manufacturing of personalized cell and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Limula Comparables
Compare Limula with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sarcura | 88% | |
| Adva Biotechnology | 87% | |
| MFX | 86% |
Limula Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Dec 11, 2024 | ||||
| Seed | May 21, 2024 | ||||
| Grant | Oct 5, 2023 | ||||
| Grant | Jun 21, 2023 | ||||
| Grant | Apr 28, 2023 | ||||
Grant | Oct 11, 2022 |
Key People
Founding team and executive leadership
Limula Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LifeX Ventures | Seed |
| European Innovation Council Fund | Grant |
| Foundation for Technological Innovation | Debt, Grant |
| Verve Ventures | Seed |
| LifeX Ventures | Seed |
| W.A. de Vigier Foundation | Seed |
| Swiss State Secretariat for Education, Research and Innovation (SERI) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 19, 2026
Limula SA is developing an automated Cell and Gene Therapy manufacturing platform.
- Jun 18, 2025
Oliver Dick joins the Strategic Advisory Board.
Limula Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Limula's valuation, stock price, and market status.
Is Limula a public or private company?
Limula is a private company.
What is the current stock price of Limula?
Limula is a private company with no public stock price. No recent secondary market data is available.
How much is Limula worth (valuation)?
Valuation information for Limula is not publicly available.
Can I buy Limula stock?
Limula shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Limula's last funding round?
Limula's most recent funding round was Seed on May 21, 2024.
Who are the main investors in Limula?
Key investors in Limula include LifeX Ventures.
Will Limula IPO soon?
No public IPO plans have been announced for Limula.
How can I track Limula secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Limula's secondary market activity and sign up for updates.